Clinical Research

Cardiol Therapeutics Inc.

Address
2265 Upper Middle Road East Suite 602

Sponsor Overview

assignment
3
sponsored trials
science
1
molecule
location_city
14
research centres
public
3
countries
person_search
16
investigators

Specializations

Inflammatory Heart Disease

Cardiol Therapeutics Inc. focuses on clinical research in acute myocarditis, with interest in improving myocardial recovery and addressing inflammation-related injury affecting the heart muscle.

  • Myocardial inflammation
  • Cardiac recovery
  • Heart muscle injury

The company’s work in this area centers on treatment strategies for patients with active inflammatory cardiac disease.

Recurrent Pericardial Disease

Another key area of interest is recurrent pericarditis, including cases linked to dependence on IL-1 blocker therapy and the risk of symptom recurrence after treatment changes.

  • Pericardial inflammation
  • Recurrence prevention
  • IL-1 pathway dependence

Research in this domain addresses long-term control of inflammatory pericardial disease and maintenance of remission.

Cardiac Anti-Inflammatory Therapy

The sponsor’s trials reflect a therapeutic focus on anti-inflammatory treatment for cardiovascular disease, with attention to tolerability and clinical benefit in inflammatory conditions affecting the heart.

  • Cardiac inflammation
  • Therapeutic tolerability
  • Inflammation-driven cardiovascular care

This area includes evaluation of treatment approaches intended to support disease control in both acute and recurrent inflammatory syndromes.

Sponsored Trials

Trial Name Country Status
Evaluation of Cannabidiol (CardiolRx) in the Management of Recurrent Pericarditis: An Open-Label Pilot StudyFrance FranceNot Recruiting
Evaluation of Cannabidiol Efficacy in Maintaining Remission Post-IL-1 Blocker Withdrawal in Recurrent Pericarditis: A Randomized, Double-Blind, Placebo-Controlled TrialGreece GreeceItaly ItalyNot Recruiting
Evaluation of Cannabidiol on Myocardial Recovery in Patients with Acute Myocarditis: A Double-Blind, Placebo-Controlled Clinical TrialFrance FranceNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
21%
Return partnership rate
3 of 14 sites collaborated multiple times

This sponsor has worked with 14 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Cardiovascular Diseases3 trials
    359 other sponsors

Partnered Research Centres

14 centres
location_city
assignment153
ASST Fatebenefratelli Sacco
Address
Via Giovanni Battista Grassi 74, 20157 Milan
Learn morearrow_forward
location_city
assignment392
Azienda Ospedaliera di Padova
Address
Via Nicolo' Giustiniani 2, 35128 Padua
Learn morearrow_forward
location_city
assignment523
Azienda Ospedaliera Universitaria Citta' Della Salute E Della Scienza Di Torino
Address
Via Cherasco 15, 10126 Turin
Learn morearrow_forward
location_city
assignment235
Azienda Sanitaria Universitaria Friuli Centrale
Address
Via Pozzuolo 330, 33100 Udine
Learn morearrow_forward
location_city
assignment1199
Centre Hospitalier Lyon Sud
Address
165 Chemin Du Grand Revoyet, 69310 Pierre Benite
Learn morearrow_forward
location_city
assignment381
Centre Hospitalier Universitaire De Caen Normandie
Address
Avenue De La Cote De Nacre, 14000 Caen
Learn morearrow_forward
Page 1 of 3

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Cardiol Therapeutics Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.